Increased risk of malignant tumors in renal transplant recipients receiving cyclosporine.
Vilardell
J
J
Department of Urology and Renal Transplant, Hospital Clinic, University of Barcelona, Spain.
Oppenheimer
F
F
Talbot-Wright
R
R
Ricart
M J
MJ
Andreu
J
J
Alcaraz
A
A
Carretero
P
P
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D009369:Neoplasms / Q000453:epidemiology* / Q000209:etiology*; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies; D012307:Risk Factors; D014184:Transplantation, Homologous
D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone